Fav of CanadaFav of Canada
  • Home
  • News
  • Money
  • Living
  • Entertainment
  • Health
  • Sci-Tech
  • Travel
  • More
    • Sports
    • Web Stories
    • Global
    • Press Release

Subscribe to Updates

Get the latest Canada's trends and updates directly to your inbox.

What's On
Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

November 18, 2026
Banking outages are ‘a matter of when, not if.’ Do you know what to do?

Banking outages are ‘a matter of when, not if.’ Do you know what to do?

November 18, 2026
Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

November 18, 2026
Facebook X (Twitter) Instagram
Fav of CanadaFav of Canada
  • Home
  • News
  • Money
  • Living
  • Entertainment
  • Health
  • Sci-Tech
  • Travel
  • More
    • Sports
    • Web Stories
    • Global
    • Press Release
Fav of CanadaFav of Canada
You are at:Home » Health Canada approves new Eli Lilly GLP-1 pill for weight loss
News

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

By favofcanada.caNovember 18, 2026No Comments3 Mins Read
Facebook Twitter Pinterest Telegram WhatsApp Email Tumblr LinkedIn
Health Canada approves new Eli Lilly GLP-1 pill for weight loss
Share
Facebook Twitter Pinterest WhatsApp Email

Health Canada has authorized a new GLP-1 medication for weight loss that is a pill taken every day, rather than weekly injections.

Eli Lilly’s Foundayo is approved for adults with obesity as well as those who are overweight and have at least one related medical problem, such as high blood pressure or sleep apnea.

In addition to promoting and maintaining weight loss, the pill is also approved to help treat Type 2 diabetes.

Eli Lilly also makes the injectable drugs Mounjaro and Zepbound, which contain the active ingredient tirzepatide. Tirzepatide acts on two receptors associated with insulin production and hunger: GLP-1 and GIP.

Competitor Novo Nordisk manufactures injectables Ozempic and Wegovy, which contain the active ingredient semaglutide. Semaglutide acts on GLP-1 receptors. Several other companies make generic semaglutide sold in Canada.

The class of drugs known as GLP-1s have revolutionized weight-loss treatment and experts say some patients may prefer to take a pill rather than an injection.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

There is another GLP-1 pill — Novo Nordisk’s Rybelsus — already on the market in Canada, but it is only approved for Type 2 diabetes management and not for weight loss.

The active ingredient in Foundayo is orforglipron, a non-peptide GLP-1 receptor agonist.

Because it’s a smaller molecule than peptides semaglutide and tirzepatide, orforglipron can be taken orally and absorbed without being broken down by the digestive system, said Dr. Ehud Ur, an endocrinologist in Vancouver who is not associated with either Eli Lilly or Novo Nordisk.

“It seems to be just as good as if not better” for weight loss as semaglutide and tirzepatide, he said.

The most common side effects of GLP-1 medications — both injectable and oral — include gastrointestinal issues, such as nausea or vomiting.


Ur said whether he would prescribe Foundayo depends on the patient, partly because he is still waiting for clinical trial results on whether or not orforglipron has a cardiovascular benefit like semaglutide and tirzepatide do.

Foundayo received Health Canada authorization on Nov. 13. Eli Lilly spokesperson Ethan Pigott said the company expects the pills to be available in pharmacies in January.

There may soon be a second GLP-1 weight-loss pill option in Canada: competitor Novo Nordisk’s Wegovy pill, which is still awaiting Health Canada approval.

Both Foundayo and the Wegovy pill are approved and available in the U.S.

Even though Wegovy is made of the large peptide molecule semaglutide, Novo Nordisk is able to manufacture it in pill form by adding an ingredient called salcaprozate sodium to protect it from being broken down by digestive enzymes.

Once the pill is swallowed, salcaprozate sodium, or SNAC, temporarily makes the area around it less acidic and helps it pass through the stomach lining into the bloodstream, Novo Nordisk spokesperson Kate Hanna said in an email on Wednesday.

&copy 2026 The Canadian Press

Related Articles

Driver ticketed after transport truck gets stuck under Fredericton bridge

Driver ticketed after transport truck gets stuck under Fredericton bridge

By favofcanada.caNovember 18, 2026
EverWind says Cape Breton AI data centre project on track despite concerns

EverWind says Cape Breton AI data centre project on track despite concerns

By favofcanada.caNovember 18, 2026
Talks with Meta ‘confidential’ following reports of possible deal, Miller says

Talks with Meta ‘confidential’ following reports of possible deal, Miller says

By favofcanada.caNovember 18, 2026
Ontario to increase fines against drivers who create excessive noise

Ontario to increase fines against drivers who create excessive noise

By favofcanada.caNovember 18, 2026
Loblaw now allows users to buy groceries via Meta’s Muse AI

Loblaw now allows users to buy groceries via Meta’s Muse AI

By favofcanada.caNovember 18, 2026
Canadian women’s flag football team to hold camp

Canadian women’s flag football team to hold camp

By favofcanada.caNovember 18, 2026
Add A Comment

Leave A Reply Cancel Reply

Don't Miss
Banking outages are ‘a matter of when, not if.’ Do you know what to do?

Banking outages are ‘a matter of when, not if.’ Do you know what to do?

By favofcanada.caNovember 18, 2026

Tech outages caused by glitches and cyberattacks are becoming more common, with a handful of…

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

November 18, 2026
Driver ticketed after transport truck gets stuck under Fredericton bridge

Driver ticketed after transport truck gets stuck under Fredericton bridge

November 18, 2026
EverWind says Cape Breton AI data centre project on track despite concerns

EverWind says Cape Breton AI data centre project on track despite concerns

November 18, 2026
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Our Picks
Raptors forward Barnes out against Wizards

Raptors forward Barnes out against Wizards

By favofcanada.caNovember 18, 2026
Robert Pattinson’s fame level was a factor in Bond casting, Jeff Bezos says

Robert Pattinson’s fame level was a factor in Bond casting, Jeff Bezos says

By favofcanada.caNovember 18, 2026
Metro says it converted 10 stores to Food Basics, with 9 more to come

Metro says it converted 10 stores to Food Basics, with 9 more to come

By favofcanada.caNovember 18, 2026
About Us
About Us

Fav of Canada is your one-stop website for the latest Canada's trends and updates, follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]
Contact: +44 7741 486006

Our Picks
Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

Flu cases have nearly doubled in 3 weeks. Is it too late to get your shot?

November 18, 2026
Banking outages are ‘a matter of when, not if.’ Do you know what to do?

Banking outages are ‘a matter of when, not if.’ Do you know what to do?

November 18, 2026
Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

November 18, 2026

Subscribe to Updates

Get the latest Canada's trends and updates directly to your inbox.

Facebook X (Twitter) Instagram Pinterest TikTok
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact
© 2026 Fav of Canada. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.